Comparison of Global Initiative for Chronic Obstructive Pulmonary Disease 2013 classification and body mass index, airflow obstruction, dyspnea, and exacerbations index in predicting mortality and exacerbations in elderly adults with chronic obstructive pulmonary disease

Journal of the American Geriatrics Society

Volumn 63, Issue 2, 2015, Pages 244-250

  Chen, Chiung Zuei ^a,b   Ou, Chih Ying ^a   Yu, Chun Hsiang ^a,b   Yang, Szu Chun ^a   Chang, Han Yu ^a   Hsiue, Tzuen Ren ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

BODEx; chronic obstructive pulmonary disease; elderly adults; exacerbations; mortality

Indexed keywords

AGED; ARTICLE; BODY MASS INDEX AIRFLOW OBSTRUCTION DYSPNEA AND EXACERBATION INDEX; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONGESTIVE HEART FAILURE; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE 2013 CLASSIFICATION; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; PREDICTION; PREVALENCE; PROSPECTIVE STUDY; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; TAIWANESE; AGE; BODY MASS; COMPARATIVE STUDY; COMPLICATION; DISEASE COURSE; HEALTH STATUS INDICATOR; PATHOPHYSIOLOGY; PREDICTIVE VALUE; TAIWAN; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; BODY MASS INDEX; COHORT STUDIES; DISEASE PROGRESSION; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS INDICATORS; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; TAIWAN;

EID: 84923315528     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13258     Document Type: Article

References (21)

1. Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: Systemic review and meta-analysis. Eur Respir J 2006; 28: 523-532.
2. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, 2006 Updated. Bethesda, MD: National Heart, Lung and Blood Institute/World Health Organization, 2006.
3. Agusti A, Calverley PM, Celli B, et al. Evaluation of COPD longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Characterization of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010; 11: 122.
4. Celli B, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-1012.
5. Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: The updated BODE index and the ADO index. Lancet 2009; 374: 704-711.
6. Soler-Catluña JJ, Martinez-García MA, Sánchez LS, et al. Severe exacerbations and BODE index: Two independent risk factors for death in male COPD patients. Respir Med 2009; 103: 692-699.
7. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, 2013 Updated [on-line]. Available at http://www.goldcopd.org/ Accessed May 5, 2013.
8. Blonshine S, Mottram CD, Wanger J,. Pulmonary Function Laboratory Management and Procedure Manual, 2nd Ed. New York: American Thoracic Society, 2005.
9. Chen CZ, Ou CY, Wang WL, et al. Using post-bronchodilator FEV1 is better than pre-bronchodilator FEV1 in evaluation of COPD severity. COPD 2012; 9: 1-5.
10. Detterbeck FC, Postmus PE, Tanoue LT,. The stage classification of lung cancer. Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians. Evidence-based clinical practice guidelines. Chest 2013; 143 (Suppl): e191S-e210S.
11. Gooneratne NS, Patel NP, Corcoran A,. Chronic obstructive pulmonary disease diagnosis and management in older adults. J Am Geriatr Soc 2010; 58: 1153-1162.
12. Fried TR, Vaz Fragoso CA, Rabow MW,. Caring for the older person with chronic obstructive pulmonary disease. JAMA 2012; 308: 1254-1263.
13. Thomas JM, Cooney LM, Fried TR,. Systematic review: Health-related characteristics of elderly hospitalized adults and nursing home residents associated with short-term mortality. J Am Geriatr Soc 2013; 61: 902-911.
14. Lange P, Marott JL, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: A study of the general population. Am J Respir Crit Care Med 2012; 186: 975-981.
15. Han MK, Muellerova H, Curran-Everett D, et al. GOLD 2011 disease severity classification in COPDGene: A prospective cohort study. Lancet Respir Med 2013; 1: 43-50.
16. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363: 1128-1138.
17. Johannessen A, Nilsen RM, Storebo M, et al. Comparison of 2011 and 2007 GOLD guidelines for predicting mortality and hospitalization. Am J Respir Crit Care Med 2013; 188: 51-59.
18. Plant PK, Elliott MW,. Chronic obstructive pulmonary disease. 9: Management of ventilatory failure in COPD. Thorax 2003; 58: 537-542.
19. Jamrozik E, Musk AW,. Respiratory health issues in the Asia-Pacific region: An overview. Respirology 2011; 16: 3-12.
20. Tan WC, Ng TP,. COPD in Asia: Where East meets West. Chest 2008; 133: 517-527.
21. Tan WC,. Trends in chronic obstructive pulmonary disease in the Asia-Pacific regions. Curr Opin Pulm Med 2011; 17: 56-61.